Literature DB >> 15729880

[A case of subacute myelitis associated with primary Sjögren syndrome showing no MRI abnormality and diagnosed by somatosensory evoked potentials].

Soichiro Fushimi1, Isao Nagano, Kentaro Deguchi, Shoko Nagotani, Tetsuro Murakami, Mikio Shoji, Koji Abe.   

Abstract

We describe a case of Sjögren syndrome presenting with subacute transverse myelopathy that improved in response to steroid therapy. A 55-year-old woman with a history of NIDDM developed progressive sensory disturbance and weakness of the both legs, and micturition disturbance during a 6-month period, resulting in walking difficulty. On admission, neurological examination revealed paraplegia with extensor plantar reflex and sensory disturbance below Th 6 level. Lumbar puncture disclosed a normal cell count and a mild elevation of protein in the CSF. As subacute myelitis at the level of Th 6 was suspected, spinal plain and enhanced MRI was performed, which revealed no abnormalities. In contrast, tibial somatosensory evoked potential (SEP) could not be evoked while median SEP was almost normal, indicating thoracic cord involvement. She was diagnosed with primary Sjögren syndrome based on xerostomia, apple-tree appearance in parotid sialography, mononuclear cell infiltration in the salivary gland biopsied, and elevated anti-SS-A and SS-B antibody titers. We considered that her myelopathy was associated with Sjögren syndrome, and started steroid pulse therapy. After three courses of steroid pulse therapy followed by oral prednisolone, she showed clinical and SEP improvements. It is conceivable that the present case may represent Sjögren syndrome complicated with myelopathy that shows no MRI abnormality and well responds to steroid therapy. SEP can be a valuable tool for assessing the presence and severity of spinal cord involvement, and the efficacy of treatments.

Entities:  

Mesh:

Year:  2004        PMID: 15729880

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  1 in total

1.  Parameters of Somatosensory Evoked Potentials in Patients with Primary Sjӧgren's Syndrome: Preliminary Results.

Authors:  Edyta Dziadkowiak; Agata Sebastian; Małgorzata Wieczorek; Elżbieta Kusińska; Marta Waliszewska-Prosół; Piotr Wiland; Maria Ejma
Journal:  J Immunol Res       Date:  2018-04-05       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.